Shiva Granito promoter warrants convert, raising ₹3.15 cr
Promoters convert 28 lakh warrants at ₹15 each, infusing 17.5% of market cap into the nano-cap tile company.
What's new
- 28 lakh convertible warrants converted into equity by promoters at ₹15 per share.
- Proceeds of ₹3.15 cr equal 17.5% of the company's ₹18 cr market cap.
- Allottees include promoter entities Brand Avenue Media and Hemant Bohra HUF.
Why this matters
For a company with a market cap of just ₹18 crore and a trailing ROE of 0.1%, a ₹3.15 crore capital infusion is substantial. It signals promoter commitment and directly strengthens the balance sheet. However, the 19% equity dilution means existing shareholders will see their stake diluted, and the tiny scale makes the company highly risky.
What we're watching
- How the company deploys the fresh capital to improve anemic ROE.
- Any follow-on share price pressure from the increased float.
- Next quarterly numbers to see if working capital constraints ease.
The full read
Shiva Granito's promoters have put their money where their mouth is — converting 28 lakh warrants into equity at ₹15 each, for a total of ₹3.15 crore. For a nano-cap with a market cap of just ₹18 crore, that's a 17.5% cash injection. The conversion also dilutes existing shareholders by about 19%, but given that the company's trailing ROE is 0.1% and it carries a P/E of 718, the cash is needed more than the dilution hurts. The move signals promoter commitment. Whether the company can turn this cash into earnings is the real test.
Questions answered
- How much cash did Shiva Granito raise from this warrant conversion?
- The company raised ₹3.15 crore by converting 28,00,000 warrants into equity shares at ₹15 each.
- Who were the allottees in this conversion?
- The allottees are promoter-linked entities including Brand Avenue Media Private Limited and Hemant Bohra HUF, among others.
- What is the impact on the company's equity base?
- The conversion adds 28 lakh new shares, resulting in an estimated 19% dilution of the existing equity base.
- Is this capital infusion material given the company's size?
- Yes, it is highly material. The proceeds equal 17.5% of the company's ₹18 crore market cap, making a significant boost to working capital.